US Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in Future

USA Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in Future

United States Insulin Pump and CGM Market Forecast Analyst View: United States insulin pump market is projected to cross US$ 5 Billion by end of the year 2022.

Press Release Title: USA Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in future For More Information: http://www.renub.com/usa-insulin-pump-market-and-cgm-market-to-cross-usd-5billion-and-usd-2-billion-in-future-47-nd.php Report Title: USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast Access Full Research: http://www.renub.com/usa-insulin-pump-market-and-users-cgm-continuousglucose-monitoring-market-and-users-reimbursement-policy-by-states-diabetestype1-and-2-population-deal-types-clinical-trials-and-forecast-1192-p.php

Get 10% Free Customization in this Report USA insulin pump market is projected to cross US$ 5 Billion by end of the year 2022. A medical device which is used for the management of insulin in the treatment of diabetes is called Š Renub Research

Page 1 of 4

www.renub.com

USA Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in Future “Insulin Pump”. Insulin Pump is a small programme device similar to mobile phone. It is very convenient to use, as this can be easily carried out. The device contains buttons to program insulin and navigates through the menu.

Nowadays in the United States, Insulin Pump has become renowned and a favored device for Type1 diabetes patients. In the United States, rising diabetic patients and increasing alertness towards diabetes, Innovation in technology Drive Insulin pump Market. The use of insulin pump is gaining recognition in the market as insulin delivery systems.

Request a free sample copy of the report: http://www.renub.com/contactus.php Renub Research, report studies in-depth analysis of Continuous Glucose Monitoring (CGM) Market in the United States.

What is Continuous Glucose Monitoring?

Continuous glucose monitoring (CGM) is a device that allows you to track your glucose continuously all through the day and night, notifying you of ups and downs so you can take action.

The United States Continuous Glucose Monitor (CGM) Market is expected to cross US$ 2 Billion in coming years. Continuous Glucose Monitor (CGM) is very important to all age groups to manage diabetes proficiently. In the United States, the market of CGM has a huge potential in coming years. From the year 2009 to 2016, Continuous Glucose Monitor users have grown to 35 percent.

Many private insurers like (Blue Cross and Blue Shield, Aetna, Cigna etc) have started reimbursing CGM based on certain criteria in the United States (Read the criteria in the report).

Many experts in the United States think that CGM is the best tool for diabetes management. For those having several diabetes complications, Continuous Glucose Monitor is very much compatible with that.

In this Report, one can study the product analysis of the United States Insulin Pumps i.e. Animas Vibe, Medtronic 530 G with Enlite, Insulet OmniPod, Tandem t: slim and Roche Accu-Chek Combo.

Access full Research: http://www.renub.com/usa-insulin-pump-market-and-users-cgmcontinuous-glucose-monitoring-market-and-users-reimbursement-policy-by-states-diabetestype1-and-2-population-deal-types-clinical-trials-and-forecast-1192-p.php

Report Studies the Reimbursement Policies of USA States - Insulin Pump, Pump Supplies & Diabetes Supplies, CGM • • • • • •

CALIFORNIA DELAWARE FLORIDA MASSACHUSETTS MICHIGAN MONTANA

© Renub Research

Page 2 of 4

www.renub.com

USA Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in Future • • • • • • • • •

NEBRASKA NEW JERSEY NEW YORK OKLAHOMA RHODE ISLAND SOUTH DAKOTA TENNESSEE TEXAS WASHINGTON

Private Insurer Reimbursement Policy for Insulin Pump & CGM • • • •

Blue Cross and Blue Shield Aetna Cigna United Healthcare

Table of Contents: 1.

Executive Summary

2.

United States Diabetes Population (2009 – 2022)

3.

United States Insulin Pump User (2009 – 2022)

4.

United States Insulin Pump Market (2009 – 2022)

5.

United States CGM (Continuous Glucose Monitoring) User (2009 – 2022)

6.

United States CGM (Continuous Glucose Monitoring) Market & Forecast

7.

Differentiation Points of Insulin Pump Products in United States

8. Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care 9. United States (By States) – Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program 10.

Top Private Insurer - Reimbursement Policy of Insulin Pump and CGM

© Renub Research

Page 3 of 4

www.renub.com

USA Insulin Pump Market and CGM Market to cross USD 5 Billion and USD 2 Billion in Future 11.

By Company – USA Insulin Pump Market Share

12.

USA Insulin Pump Market – Major Deal Types

13.

Companies - Insulin Pump Clinical Trials

14.

United States – Key Player Analysis

15.

Growth Drivers

16.

Challenges

Medical Devices Market Report: http://www.renub.com/medical-devices-15-c.php

Renub Research - North America

Renub Research - Asia

Rajat Gupta

Ankit Mishra

225 Kristie Ln, Roswell

C – 86, Sector – 10

Georgia 30076, United States

Noida 201301, India

Tel: +1-678-302-0700

Tel: +91-120-421-9822

Email: info@renub.com

Email: info@renub.com

www.renub.com

www.renub.com

© Renub Research

Page 4 of 4

www.renub.com